Evidence map›Paper›PMID 31832807›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Prevalence of urogenital mycoplasmas in women with systemic lupus erythematosus (SLE): preliminary study.

Ekiel Alicja, Romanik Małgorzata, Aptekorz Małgorzata, Semik-Grabarczyk Elżbieta, Cieślik Paweł, Smolec Dominika, Jóźwiak Jarosław, Holecki Michał, Martirosian Gayane

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Lupus Nephritis and Dysbiosis.Biomedicines · 2023
    Review
  2. Article
  3. Frontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ekiel AlicjaDepartment of Medical Microbiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. aekiel@sum.edu.pl.ORCID http://orcid.org/0000-0002-4603-9758
Romanik MałgorzataDepartment of Medical Microbiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0003-0377-9833
Aptekorz MałgorzataDepartment of Medical Microbiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0002-7343-4702
Semik-Grabarczyk ElżbietaDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0002-7871-528X
Cieślik PawełDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0002-3723-3591
Smolec DominikaDepartment of Medical Microbiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0001-8601-1752
Jóźwiak JarosławDepartment of Histology and Embryology Warsaw Medical University, Warsaw, Poland.ORCID http://orcid.org/0000-0002-2998-6542
Holecki MichałDepartment of Internal, Autoimmune and Metabolic Diseases, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0002-3289-1050
Martirosian GayaneDepartment of Medical Microbiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.ORCID http://orcid.org/0000-0002-0311-0884
Medical University of Silesia · PLMedical University of Warsaw · PL

Funding

The study is supported by the Medical University of Silesia KNW-1-061/K/8/O
6 · The paper itself

Abstract

The aim of this study was to determine the occurrence of urogenital mycoplasmas in urogenital tract of women with systemic lupus erythematosus (SLE). The study group included 36 women diagnosed with SLE and 100 healthy controls. Mycoplasmas were detected with microculture and PCR in 13/36 (36.1%) women with SLE and in 25/100 (25%) controls. In both groups, U. parvum occurred significantly more frequently. M. genitalium was detected in 3/36 (8.3%) SLE patients and in 3/100 (3%) controls. FVU as a material decreased the number of positive results from 33.3% to 30.6% compared with swabs.Although the incidence of mycoplasmas in urogenital tract of women with SLE and controls did not differ statistically, it is important to consider them as a potential etiology of urogenital infection when clinical symptoms are present, but etiology is unknown or uncertain.

Indexed as

AdultFemaleFemale Urogenital DiseasesHumansLupus Erythematosus, SystemicMiddle AgedMycoplasmaMycoplasma InfectionsPolandPreliminary DataPrevalenceUreaplasma InfectionsUreaplasma urealyticumUrogenital SystemYoung AdultMycoplasma genitaliumMycoplasma hominisSystemic lupus erythematosusUreaplasma parvumUreaplasma urealyticum

Identifiers

PMID31832807
OpenAlexW2995157763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.